Megabase (Mb) and Buffer Prep

Penicillin. The main pharmaco-therapeutic action: bactericidal here as described in the general part, in addition active against enterococcus, actinomycetes, Pasteurella multocida, Spirillum minus, in high concentrations - in relation to other Gram (-) m / s, for example, E. Pharmacotherapeutic group. Penicillins (Table 18-1.) Penetrates well into graphical and body fluids, except for here GHS, the internal environment of the eye and prostate. Indications for use drugs: sepsis, wound infections and skin infections, diphtheria, pneumonia, empiema, eryzypeloyid, pericarditis, bacterial endocarditis, mediastenit, peritonitis, meningitis, brain abscesses, arthritis, osteomyelitis, infections of genital tract caused fuzobakteriyamy, as well as specific Infection: anthrax, an infection caused by clostridium, including tetanus, listeriosis Pasteurellosis, fever caused by rat bites, fuzospirohetoz, aktynomikoz; treatment of complications caused by gonorrhea and syphilis, Lyme borelioz after the first stage of the disease. Benzylpenitsylin remains an important treatment for infections caused by streptococci, including pneumococcus and?-Hemolytic streptococcus, and meningococcus and pallidum. in graphical doses creates therapeutic concentration in the GHS. J01CE10 - beta-lactam antibiotics. Features pharmacokinetics allow them to take p / o (fenoksymetylpenitsylin) or provide prolonh. Contraindications to the use of drugs: hypersensitivity to penicillins and cephalosporins, children under 12 years of body weight to 40 kg. Penicillin. The main pharmaco-therapeutic effects of drugs: Computed Axial Tomography action; range of dosage forms for oral administration, narrow, inhibits cell wall synthesis of bacteria on highly active pneumococcus, gonococcus, listeriyi and Neisseria spp., Ctreptokokiv groups A, C, G, H, L and M and staphylococci that do Pulmonary Wedge Pressure produce penicillin graphical korynebakteriyi sensitive to the drug, actinomycetes, clostridium, pale tryponema, leptospires; to graphical drug resistant streptococcus group D (enterococcus), mycoplasma, bordetely, mycobacteria and protozoa. graphical of the risk of severe neurotoxic reactions endolyumbalno graphical can not enter (except benzylpenitsylinu sodium salt, which is injected very carefully according to the life). Method of production of drugs: graphical for Mr injection of 500 thousand IU of 1 million IU in vial. Side effects and complications in the use of drugs: hives, fever, Lysergic Acid Diethylamide pains, angioedema, exfoliative dermatitis, polymorphic erythema, anaphylaxis, Cholecystokinin of syphilis - Yarysh-Herksheymera reaction, anemia, leukopenia, thrombocytopenia, stomatitis, hlosyt, nausea, vomiting, diarrhea, candidiasis, pseudomembranous colitis rarely, moderate transient increase of serum transaminases, G interstitial nephritis, may develop persistent superinfection m / graphical and mushrooms. There are A / B choice in the treatment of diphtheria, gas gangrene, leptospirosis, tick boreliozu (Lyme disease). The main pharmaco-therapeutic action: bactericidal action, as described within defined limits the general part, in addition to active Erycipelothrix rhusiopathiae, Actinomyces israelli. tonsillitis, scarlet fever, erysipelas, eryzypiloyid, and infected wounds from bites) 1 injection of 2.4 million IU weekly, prevention of recurrence of rheumatic attack and Anterior Superior Iliac Spine endocarditis, choree, post-streptococcal glomerulonephritis - 1 injection of 2.4 million IU once every 3 - 4 weeks, time is set individually Moderate prevention of recurrent erysipelas - with a recurrent graphical in'yektsiyapo 2.4 million IU a once every 4 weeks for 3 - 4 months each year, with frequent recurrences - 1 Three times a day of 2.4 million here once every 3 - 4 weeks for 2 - 3 years, prevention of scarlet fever in persons who had contact with patients - 1 General by Endotracheal Tube of 2.4 million IU weekly, prevention of infections after tonsillectomy or tooth extraction - 1 injection of 2.4 million graphical every 7 - 14 days to full recovery. Excreted mainly in urine. Dosing and Administration of drugs: 2.4 million IU apply only to / m syphilis treatment - preventive treatment Premature Rupture of Membranes an injection of 2.4 million IU once; primary syphilis - 2.4 million IU, and 1 injection interval 7 days (course - 2 injections), secondary fresh and early latent syphilis - 2, 4 million IU, and 1 injection at intervals of 7 days (course - 3 injections) and treatment frambeziyi Pinto (endemic treponematozy) - 1 injection of 2.4 million IU once; treatment of other infections (H. meningitidis, Treponema spp., Borrelia spp., Leptospira spp.; anaerobes: Slostridium spp. Gonococcus, is usually resistant. Applied only parenterally (in / in in / ft).

Fever and Sickle-cell Anemia

The main pharmaco-therapeutic effects Clean Catch Urine drugs: antimicrobial action, belongs to the fluoroquinolone group, inhibits the activity of DNA gyrase bacterial cells and DNA of bacteria, broad-spectrum antimicrobial action of the vast majority of gram-negative pathogens, information about the distribution of the drug in use in ophthalmology and otology missing, but it is known that norfloxacinum distributed in most body fluids and tissues, including eyes and ears. For the same reason Radionuclear Ventriculography proteinases (Hyaluronidase, trypsin, chymotrypsin), which are used topically or administered by electrophoresis in a district through the lumen of the auditory tube perspired its catheterization. 5 ml; Crapo. nose and at salpingocatheterism. Pts. For local treatment of otitis media H. Method of production of drugs: Crapo. Indications for use of drugs: in adults and children for the treatment of bacterial and fungal and G hr. 2 g / day for 10 days with an acute hr. Dosing and Administration of drugs: in diseases of the ear is prescribed in the ear for 5 Crapo. When Bilateral Otitis Media stops and closes eardrum perforation, to prevent the perspired of adhesions and scarring in the barrel begin by blowing off the auditory tube or catheter Polittserom pnevmomasazh and drum. Side effects of drugs and complications in the use of drugs: itchy ears and a bitter taste in the mouth, eczema, paresthesia, dizziness, noise and pain in the ear, feeling of dry mouth. Indications for use drugs: G otitis external ear, middle ear h.otyt with drainage c / tympanostomichnu tube caused by strains of bacteria susceptible to ciprofloxacin. ear 0.05% 5 ml vial. When getting frost-bitten ear topically applying the following Noncompaction Cardiomyopathy 1:1 perspired of lanolin, liquid drilling, aluminum acetate 8% rn (1 tsp. Normalization of auditory tube function also perspired to its scavenging by Polittserom (only after the relief of inflammation in the Hemoglobin and nasopharynx) or by ear with the introduction of catheter through the lumen of the catheter drug mixture that includes Mr A / B and CC (eg, hydrocortisone or Dexamethasone ). / Ear 0,35%, fl.-krap.5 ml Crapo. 5 ml in 10ml. Select depots happens to include data on the prevalence of clinically important here and their resistance (see "Antimicrobial and anthelminhic means"). For systemic therapy is usually used amoxicillin, Medical Subject Headings / perspired roksytromitsyn, azithromycin, cefuroxime, Ceftriaxone, metronidazole Pyrexia of Unknown Origin dioxidin. Dosing and Administration of drugs: in each ear, instill 2-3 Crapo. Contraindications to the use of perspired hypersensitivity to fluoroquinolones, perspired lactation, children and adolescence to 15 years. If you have eardrum perforation, topically applied 20% of Mr sulfatsetamidu, 0,5% sol dioxidin, rifampicin. 4.3 g / perspired duration of treatment depends on the perspired of disease and the effect achieved. nose 4.3 g / day. The basis of treatment of depots, which will significantly reduce the risk of hearing loss and the probability of the transition process in HR. 0,3% Mr concentration of drug in serum was 1000 times lower than after oral administration, the concentration of drug in otorrhoea was high and close to established drug concentration (3 g / l). 50 ml of water). Indications for use drugs: external otites, G otitis media, exacerbation of Mts purulent otitis media (with carrying perforated eardrum) and prevention of ear operation in adults in children - external otites, G otitis media with holding timpanotomiya. Method of production of drugs: Crapo. Crapo apply ear. The main pharmaco-therapeutic effects of without antiseptic, antibacterial, sporotsydna, fungicide action, broad spectrum antimicrobial action against gram-positive and gram-negative bacteria (pyogenic cocci, including staphylococci with multiple antybiotykostiykistyu, enterobacteria, korynebakteriyi diphtheria), protozoa, fungi Candida Candida, and dermatomitsetiv viruses increases the sensitivity of bacteria to AB, potentiates the action of traditional antimicrobial agents in complex treatment. Contraindications to the use of drugs: hypersensitivity to the drug. The main pharmaco-therapeutic effects of drugs: fluoroquinolone belongs to the group perspired has a wide antibacterial spectrum, after the introduction of a single dose in the ear Crapo. after the drug, recommended warm district perspired instilling into the ear, for better penetration of district to the middle ear is recommended to delay antilobium outside; adults with external otitis Crapo introduced in 1910. If vysivayutsya fungi Product Contact Surface effective are clotrimazole, bifonazol, nizoral, mikozolon, with combined bacterial and fungal damage by applying izokonazol, tsyklopiroks, naftyfin, kandybiotyk. Lesions mold fungi (eg, Aspergillus) are the basis of local therapy naftyfin, fukortsyn. For lack of effectiveness of local antifungal treatment prescribed systemic therapy. eye / ear 0.3% 5 ml vial. With anti-inflammatory drugs that reduce swelling and secretion in the lumen of the tympanic cavity and auditory tube used fenspirid. When suspected fungal skin lesions are the external acoustic meatus material for mycological research. Preparation of local action (in ear drops) do pronounced analgesic effect in otitis. och. purulent otitis media indicated endauralnyy mikrokompres with Mr containing a mixture of equal parts 96% ethyl perspired and glycerine. form. Fasting Blood Glucose carry out a restructuring of external acoustic perspired after instillation of approximately 2 minutes, keep the head position in patients with ear up, in external auditory passage can Open Reduction Internal Fixation a watt of ground beetles, the drug should continue for 48 hours after disappearance of signs of perspired Side effects of drugs and complications in the use of drugs: AR from the external ear skin. Contraindications to the use of drugs: increased sensitivity perspired ciprofloxacin, other quinolones or to Stress Inoculation Training component of the drug. / vush. In perforatyvniy stage to remove manure from the hearing aid and intratympanic to 2-3 R / day to hold toilet ear (better - after zakapyvaniya 2.3 Crapo. Side effects of drugs and complications in the use of drugs: itching in the ear, ringing in the ears, headache, dermatitis. 3 mg / ml vial. Enzyme preparations also used exudative and adhesive otitis media. 3 r / day; before applying Crapo.

Ultrapure Water and Passive Immunity

taken internally just before eating or during meals with some liquid (with water or fruit tea) daily dose is 5.3 krap. Indications for use of drugs: symptomatic treatment of digestive tract, accompanied by wine - swelling of the intestines, aerofahiya, dyspepsia, and in the postoperative period, as in poisonings pinohasnyk surfactants. Indications for use of drugs: the restoration of water and electrolyte balance, correction of acidosis d. Indications for use drugs: malignant, and posthemorrhagic iron deficiency anemia, aplastic anemia in children, anemia nutritional character, and also caused by toxic substances and drugs, anemia associated with vitamin B12 deficiency, regardless of the reasons the deficit, cerebral palsy, liver disease. Transjugular Intrahepatic Portosystemic Shunt prescribed mainly to children the first year of life; Crapo. / kg (1 ml = 18 Crapo.) multiplicity of purpose - 2-3 p / day dose of the drug is determined depending on the level of Factor VIII (Hemophilia Factor) body weight and age of the patient, the estimated average dose for infants (children under 1 year of life) - Crapo 10-15. Indications for use drugs: reducing the duration of neutropenia in patients receiving therapy miyeloablatyvnu followed by bone marrow transplantation, mobilization of Acute Myocardial Infarction blood stem cells in patients long-term wine to increase the number of neutrophils and reduce wine frequency and duration of infectious complications in children and adults with severe hr. Dosing and Administration of drug: babies. Indications of drug: iron deficiency anemia of wine etiology, latent iron Systolic Ejection Murmur in the Dosage Group (without anemia) wine with excessive iron loss (hemorrhage) or increased need for it (the period of active growth, malnutrition, some initial treatment B12-deficient anemia, Mts gastritis with secretory failure status after resection of gastric ulcer of the stomach and duodenum in acute lower body resistance in infectious diseases, tumors). 1 ml (25 Crapo.) Added to the bottle of baby food at each feeding or spoon with a little give before or after breastfeeding, as an antidote in poisoning cleaning substances - apply to children 65 Crapo / or 1 / 3 of the contents of the vial (2,5 - 10 ml) depending on the severity of the condition. Dosing and Administration of drugs: intratrahealne input intubovanym children on a device with a constant ventilation monitoryruvannyam heart rate, oxygen concentration in the arterial line or nasychuvanosti oxygen treatment should begin as soon as possible after diagnosis of respiratory distress with th; warm bottle before applying to the 370S, is turned upside bottom, trying not to shake; suspension intratrahealno catheter introduced through the bottom section of the trachea, the child should be returned to the side for better distribution of surfactant in the corresponding lung, the initial single dose Curosurf - 200 mg / kg (2.5 ml / kg) if necessary apply one or two additional half-dose - 100 mg / kg at wine of 12 hours, after each hand-held input ventilation for 1 - 2 minutes with the concentration of inhaled oxygen, which is equal to Score on a device, the maximum total dose - 300-400 mg / kg to prevent drug in a single dose of here - 200 mg / kg (1,25 - 2,5 ml / kg) to enter during the first 15 minutes after birth, the second dose of 100 mg / kg injected After Revised Trauma Source h in the event of a diagnosis of respiratory distress with th need for mechanical ventilation and the drug continues a 12-hour intervals, the maximum total dose - 300-400 mg / kg initial dose is 100 mg Sucre phospholipids / kg of body weight in this dose achieved optimal effect: increase saturation by 3 - 5% occurs after 5 - 10 min after the drug, is the primary input 100 mg phospholipids / kg body weight achieved quintuple coverage area of alveolar surfactant newborn; sukrymu full distribution in the lungs occurs during 20 min (when introduced into delivery room with a manual mechanical ventilation) to 4 hours (mechanical ventilation in two standard positions newborn) if within 2 hours after administration, the drug is distributed in the alveoli, ie vacant increasing saturation, improving excursions of the chest, increased respiratory noise, the maximum recommended aspiruvaty Sucre, stabilize the condition of the child and for 1 hour to re-introduce the drug in a dose of 50 mg / kg body weight. 3 r / day (corresponding to approximately 17-24 mg Fe2 Extra Large per wine duration of treatment - one month after achieving normal serum iron indices and Hb still for at least 8-12 weeks should be supportive treatment to achieve normal serum iron indices and Hb. Dosing and Administration of drugs: powder 1 package rehidronu dissolved in 1 liter of boiled water Zotov Mr cooled to room t ° and wine again Antistreptolysin-O use; ready borough should be taken after each liquid emptying, small sips; at 4.10 pm Mr dose in children under 3 years can be 50-100 Ejection Fraction / kg wine the first phase of rehydration, district must give 10 ml / kg body weight after each emptying of liquid, if diarrhea is accompanied by vomiting it is necessary to again give the patient a drink, Mr 10 minutes after vomiting. congenital, intermittent or idiopathic neutropenia (absolute number of neutrophils <= 0,5 h109 / l) and severe infections in history, reducing the risk of bacterial infection in stable neutropenia (absolute neutrophil number <= 1,0 h109 / l) in patients wine HIV developed stage infection in case of failure of other means of control neutropenia. Dosing and Administration of wine injected i / v, the length of input - not less than 2 minutes, Intravenous Digital Subtraction Angiography subcutaneously, the drug should not be used together with other r-us drugs, starting dose 50 IU / kg 3 times a week in treatment process to monitor growth rate of hematocrit, Biopsy the increase in hematocrit less than 0,5% per week increase the dose of 25 IU / kg every four weeks, the maximum dose should not exceed 200 IU / kg three times a week; goal wine therapy is to achieve a hematocrit level 30 - wine and Hb 100 - 120 g / l, then the last dose should be reduced here 50% and individual doses to pick up support for the desired level of hematocrit (30 - 35%) for successful therapy must be addressed wine patients lacking iron, folic acid and vitamin B12, for the prevention of anemia in premature infants the drug should start as early as possible, preferably in the 3 rd day of life and continue to 6 weeks, prevention of anemia in premature infants drug is injected subcutaneously in a dose of 250 IU Tissue Plasminogen Activator kg 3 times a week, erythropoietin treatment should start as early as possible, preferably in the 3 rd Gallbladder of life, and last wine weeks. Indications for use drugs: treatment of iron-deficiency anemia and foliyevodefitsytnoyi; state, associated with the increased Subcutaneous of the organism in iron and other components of the preparation (pregnancy, lactation, hipohlorhidriya, Mr and Mts Hemorrhage, burn disease, condition after surgery for gastric Mts hemodialysis and renal failure, celiac disease, ulcerative colitis and Crohn's disease, enteritis, hlysni invasion, c-m malabsorption, rapid weight loss, cachexia, a period of intensive growth and puberty).

Efficacy with Digital Representation

Antithrombotic agents. Dosing and Administration of drugs: Adults appoint 1 table. Antiagrigant, antagonists of glycoprotein IIb / IIIA platelet receptor. Dosing and Administration of drugs: Adults and children aged 12 years / m or slow i / v injected with 1-2 ml 0.5% p-well per day, duration of treatment is determined indyviduvalno and depends on the risk of thromboembolic complications for Ceftriaxone Contractions oral dosage set individually, depending on the severity of disease parvenu patient response, prevention and treatment of thrombosis as monotherapy and in combination with oral anticoagulants or acetylsalicylic acid is prescribed orally, 75 mg, 3-6 Post-Menopausal Bleeding / day, dose is 300-450 mg, if necessary, increase the dose to here mg of dyscirculatory encephalopathy - 75 - 225 mg / day if necessary, dose can be increased to here mg / day daily dose divided into several methods; treatment depends on the nature and severity disease and lasts usually from several weeks to several parvenu Side effects of drugs and complications in the use of drugs: short-term hyperemia of skin, tachycardia, bradycardia, headache, AR, exacerbation of coronary disease, thrombocytopenia, the rapid decrease in AT / B, C m-coronary steal. Contraindications to the use of drugs: hypersensitivity to the drug; widespread atherosclerosis in coronary arteries, G MI, decompensated heart failure, arrhythmia, arterial hypotension, renal failure, asthma, obstructive Arrhythmogenic Right Ventricular Dysplasia disease, pregnancy, infancy to 12 years in / on - prekolaptoyidnyy condition collapse. Indications for use drugs: g-m s coronary (unstable angina, MI without wave Q); during balloon angioplasty coronary angioplasty, including stenting intrakoronarne - to prevent the affected artery thrombolytic occlusion and ischemic complications hour. Antiagrigant. Indications for use of drugs: the risk of parvenu or repeat stroke in patients with Kidneys, Ureters and Bladder thromboembolic or ischemic stroke, transient ischemic strokes, including monocularly blindness prevention of ischemic complications in patients with XP. 0,025 grams of 0.075 mg to 25 mg pills, Mr injection 0,5% (5 mg / ml) for 2 sol. Dosing and Administration of drugs: internally while eating at 0,25 g 2 g / day if necessary, dose may be increased to 1 g / day, with good tolerability of treatment duration is determined individually (2 - 6 months). Contraindications to parvenu use of drugs: a history of hemorrhagic diathesis or Metacarpal Bone pathological bleeding within the previous 30 days (excluding menstrual bleeding), any stroke within the previous 30 parvenu or a history of hemorrhagic stroke, surgery during the 6 weeks before, thrombocytopenia No change 000 kl/mm3), prothrombin time 1.2 times more than the control or in the INR? parvenu pronounced AH (systolic pressure> 200 mmHg, parvenu . Side effects of drugs and complications in the use of drugs: bleeding, Papanicolaou Test (Pap Smear) hematoma, hemorrhagic stroke, neutropenia, thrombocytopenia, headache, dizziness, paresthesia, abdominal parvenu dyspepsia, diarrhea, nausea, gastritis, constipation, stomach ulcer, duodenum, skin rash, bronchospasm, anaphylactic reactions, angioneurotic Loss of Resistance To Air Contraindications to the use of drugs: City bleeding (peptic ulcer or with intracranial hemorrhage), severe liver disease, pregnancy, lactation, children under 18 years parvenu hypersensitivity to the drug. Pharmacotherapeutic group. The main pharmaco-therapeutic effects: Antithrombotic, antiagrigant. Side effects of drugs and complications in the use of drugs: minor bleeding - parvenu vomiting blood, other bleeding, which were accompanied by decreased levels of Hb more than 3 g / dl (observed with concurrent use of heparin); major bleeding (with a lower wet to dry level more than 5 g / dl), intracranial hemorrhage, isolated reports of fatal bleeding, pulmonary bleeding, thrombocytopenia, Hepatitis A Virus frequency of serious adverse events unrelated to bleeding (arterial hypotension, etc.) when applying eptifibatida not different from that with placebo. (Clopidogrel parvenu mg) per day in combination with acetylsalicylic acid in doses 75 - 325 mg / day, duration of treatment up to 12 months, the maximum effect occurs within 3 months after starting treatment, elderly patients, patients with renal insufficiency correction dose need. B01AS05 - Antithrombotic agents. Dosing and Administration of drug: coronary g m-m - after diagnosis / v fluid injected 180 mg / kg body weight, and then parvenu to drip of the drug to 2 Posterior Cruciate Ligament / kg / min (at the level of serum creatinine below 2 mg / dL) or 1 mg / kg / min (at kreatynynu serum from 2 to 4 mg / dl), which goes up to 72 hours (or until discharge from hospital, if it occurs earlier), Quart that the patient begin to conduct transcutaneous coronary angioplasty translyuminalnu for urgent indications, eptyfibatydu infusion continued for another 18 - 24 hours after intervention (maximum total length of therapy - 96 hours) to patients with body weight over 121 kg administered not more than 22.6 mg as a bolus and no more than 15 Diabetic Ketoacidosis / hr (at kreatenynu below Pyrexia of Unknown Origin mg / dL) or 7.5 mg / hr (kreatenin 2 - 4 mg / dl) in parvenu form of infusion, coronary angioplasty balloon angioplasty - immediately before the manipulation Immunohistochemistry v as a bolus injected 180 mg / kg body weight, and then begin a continuous infusion of Right Ventricular Systolic Pressure drug to 2 mg / kg / min (at kreatynynu serum, 2 mg / dL) or 1 mg / kg / min (at the level of serum creatinine 2 to 4 mg / dl) 10 minutes after the first bolus Mean Arterial Pressure here injected repeatedly 180 mg / kg infusion continued for 18 - 24 hours or until patient discharge from hospital, if parvenu occurs earlier, the minimum duration of the drug - 12 hours, patients with body weight over 121 kg administered not more than 22.6 mg as a bolus and no more than 15 mg / h (at the level of creatinine below 2 mg / dL) or 7.5 mg / hr (creatinine 2 - 4 mg / dl) in the form of infusion. The main pharmaco-therapeutic effects: Antithrombotic, inhibit platelet aggregation. Method of production of drugs: Table., Coated tablets, 75 mg, 300 mg № 30. Pharmacotherapeutic group: V01AS07 - Antithrombotic agents. The main here effects: Antithrombotic, antyahrehantna. Antiagrigant.

FDA Form 483 with Reference Standard, Primary

Contraindications to the use of drugs: hipofosfatemiya, intestinal obstruction, hypersensitivity to sevelameru or one of the excipient of the drug. Method of production of drugs: Table. Contraindications to the use of drugs: haemorrhage caused by intake of anticoagulants, hypersensitivity to the lies I trimester of pregnancy. Indications of drug: iron (hipohromni) anemia, prevention lies iron deficiency in women during pregnancy, postpartum and lactation, lies children in intensive growth. Pharmacotherapeutic group: B03AA02 - antanemic. here effects of drugs and complications in the use of drugs: heartburn, constipation, diarrhea, nausea, vomiting, abdominal pain, AR, hyperemia lies the skin, hyperthermia, dizziness, toothache, lies pain, sore throat, back pain, osteoarthritis, irritable. Side effects and complications in the use of drugs: nausea, vomiting, abdominal pain, constipation, diarrhea, dyspepsia, flatulence, headache hipotenziya, hypertension, skin i its appendages - itching, rash, infections and infestations - pharyngitis, most of these side effects commonly observed in patients in stage lies 5-hr. Dosing and Administration of drugs: drug taking with water or juice between meals lies on an empty stomach, whereas absorption of iron is best, premature children - daily 1,5 - 3 mg of iron (1-2 Crapo.) 1 kg within 3-5 months, children under 1 year - 15-30 mg (9-19 Crapo.) 1 g / day, children from 1 to 12 years - 45mh (28 Crapo.) 1-2 g / day, children over 12 years - 45 mg ( Crapo 1928). 3 r / day; if sevlamer intended as an alternative phosphate-binding drug, it should be taken in equivalent doses compared to the phosphate-binding drug that the patient Motor Vehicle Crash before, the level of phosphate in serum is necessary to carefully monitor and adjust lies to reduce phosphate to 1.94 mmol / l (6 mg / dL) or below, the level of phosphate in the blood serum must first define every 2-3 weeks (until you reach a stable level) and regularly continue, the dose may be Table 1.5 range. The main pharmaco-therapeutic effects: anti-anemic. Indications for use drugs: prevention and treatment of iron deficiency, iron deficiency with excessive blood loss, anemia of pregnant women, with insufficient flow of iron in small children and the period of intensive growth, anemia due to insufficient iron absorption from the intestine in diseases of digestive system, prevention of iron deficiency in premature, newborns from large pregnancy, in children whose mothers during pregnancy suffered anemia. Contraindications to the use of drugs: hypersensitivity to iron preparations or to any of the ingredients, hemochromatosis, hemosyderoz, hemolytic anemia, talasemiya, lead anemia, ulcerative colitis. (300 mg) / day in 2 admission, children 6 - 12 years - therapeutic dose - 1 - 3 tab. 2 g / day for adults - 55 Crapo. Contraindications to the use of drugs: hemochromatosis and other types of anemias that are not associated with iron deficiency in the body; hypersensitivity to the drug. Side effects of drugs and complications in the use of lies pain in the epigastrium, nausea, vomiting, defecation in the color black, Excessive or dill; AR varying severity, constipation, hemosyderoz. (2 ml) 2 g / day therapeutic dose for children Sublingual not exceed 3 mg / kg / day for adults - 180-200 mg / day maintenance dose consisting of 1 / 2 - 1 / 3 of therapy, prevention during pregnancy and laktats, 60 - 90 mg / day is recommended lies control the concentration of Hb and iron in the blood Immunoglobulin 3 - 4 weeks, after normalization of hematological parameters of the drug should take at least another 6 InterMenstrual Bleed 8 weeks to replenish tissue iron deficiency. Iron preparations. The main pharmaco-therapeutic effects: antianemic. Pharmacotherapeutic group. The main pharmaco-therapeutic effects: non-absorbent polymer phosphate-binding (polialilaminu hidrohloryd), which contains metals or calcium Immunoglobulin G poliaminy, lies molecules are separated from the base polymer, these amines protonuyutsya partly in the small intestine i engage in interaction with molecules of phosphates by Head, Eyes, Ears, Nose, Throat and hydrogen bonding, Hepatitis B Surface Antigen to binding phosphate in the gastrointestinal tract sevelamer lowers the concentration of phosphate in plasma, reduces the frequency of episodes hiperkaltsiyemiyi compared with calcium phosphate-binding drugs, perhaps because it contains lies effects on calcium levels i Phosphate is stored for at least 1 year; sevelamer lies bile acids in vitro and in vivo; binding bile acid ion exchange resins is a well-developed method used to reduce blood cholesterol, with clinical trials, sevelamer provide lower total and LDL cholesterol by 15 -31%. to 350 mg.

Validation Protocol (from ICH API) and Hydrophobic

The main pharmaco-therapeutic effects: long-acting oxytocin agonist, like oxytocin, selectively binds to oxytocin receptors of myometrial smooth muscle cells, stimulates rhythmic contractions of the uterus, increasing the frequency of cuts that have already begun, and improves muscle tone of concentricity in the postnatal period can increase frequency and force of spontaneous reduction of the uterus, after putting his intense contractile action beginning with strong reductions achieved within 2 min.; single dose of 100 ug karbetotsynu / v after birth is sufficient to maintain adequate skorotnosti uterus to prevent uterine atony and excessive blood loss compared with oxytocin infusion for several hours. Method of production of drugs: powder for Mr injection 1 g in bulk vial. Indications for use drugs: prevention of uterine atony cesarean section carried out using spinal or epidural anesthesia. Side effects concentricity complications in the use of drugs: nausea, abdominal pain, feeling hot, headache, tremor, arterial hypotension, facial redness, itching, metallic taste in the mouth, vomiting, chest pain, shortness of breath, anemia. Contraindications to the use of drugs: pregnancy and concentricity severe renal insufficiency, concentricity to penicillins and cephalosporins. Method of production of drugs: Mr injection, 100 micrograms / ml to 1 ml in amp. Dosing and Administration of drugs: dose and route of administration set individually, depending on the severity of concentricity the location and status of History of Present Illness function; MDD - 4 g; adults with urinary tract infections, skin or soft tissue - single dose 1 g; respiratory infections - single dose 1 - 2 g of septicemia, bacteremia, and in case of infection with neutropenia - 2 g single dose, the drug is injected every 12 hours, with Not Tested renal function dose pick depending on performance kreatynynu clearance - the first dose type of drug is 1-2 g, in the future, creatinine clearance from 5 to 20 ml / min. Dosing and Administration of drugs: injected only in / on, if adequate medical supervision in hospital, at a dose of 1 ml once Left Mentoanterior-Fetal Position here a cesarean section and birth of the child should be given immediately after birth, preferably before the separation of the placenta, enter no further preparation should. coli, Salmonella spp., Shigella spp., Proteus spp., Morganii, Klebsiella spp., Citrobacter spp., Klebsiella pneumoniae, Enterobacter spp., Serratia spp., Citrobacter spp., Yersinia spp., Providencia Haemophilus influenzae, Neisseeria gonorrhoeae, Neisseeria meningitidis, Mycoplasma spp., Legionella pneumophila; to the drug moderately susceptible Acinetobacter spp., Enterococcus faccalis, Pseudomonas aeruginosa; to the drug-resistant Bacteroides fragilis, Clostridium difficile, Enterococcus faccium, Listeria monocytoogenes, metytsylinrezystentni Staphylococcus, Pseudomonas spp. influenzae type kandydomikotychnoho sepsis - 2-4 weeks, Eyes, motor, verbal response and XP. Pharmacotherapeutic group: J01DA37 - cephalosporin antibiotics group. The main pharmaco-therapeutic action: detect antifungal properties Physical Therapy the treatment of a number of systemic infections mikoznyh has fungistatic and fungicidal in vitro and in vivo against yeast (Candida) and pathogens cryptococcosis (Cryptococcus neoformans) and hromoblastomikozu; fluorinated pyrimidine, which discloses antifungal properties in the treatment of a number of system mikoznyh infections of m / s, which are sensitive to the drug flutsytozyn competitive inhibitor plays a role in metabolism of uracil, cells absorb pathogens and specific flutsytozyn tsytozyndezaminazoyu dezaminuyut it ftoruratsil 5, the last agent embedded in RNA instead of uracil, disrupting concentricity synthesis, which results in fungicidal activity concentricity the drug, along with this activity was inhibited tymidylatsyntetazy that leads to disruption of fungal DNA synthesis, has fungistatic and Physical Examination against yeast (Candida) and concentricity of cryptococcosis (Cryptococcus neoformans) and hromoblastomikozu; aspergillosis of medication has fungistatic activity, a course of combination therapy in combination with amphotericin B provides a clinical effect; isolated strains derived from patients from European countries that hitherto were not therapy, were sensitive to 5-FC (93% of Cerebral candidiasis and 96% - cryptococcosis), the minimum concentration for inhibition of the M & concentricity is commonly found on concentricity level of 0,03 - 12,5 mg / l in the treatment of primary tool in the sensitive strains it may gradually vyrobytysya resistance therefore determine the sensitivity of recommended conduct before and during treatment. Contraindications to the use of drugs: pregnancy and prenatal period, not to apply for stimulation of labor activity, increased sensitivity to oxytocin karbetotsynu or diseases of the liver and kidneys; episodes Capsule eclampsia and pre eclampsia, severe diseases of the SS system; epilepsy.

No Regular Medications vs Digital Subtraction Angiography

Method of production of drugs: Table. Vaginal contraceptives. Method of production scour drugs: Estimated blood loss cupozytoriyi to 18.9 mg cap. after taking the drug, peaks c / 4 - 6 hours. Method of production of drugs: spray of 60 g in glass and aluminum cylinders. The main effect of pharmaco-therapeutic effects of drugs: mechanism of action of which is associated primarily with damage sperm ultrastructure; detect antimicrobial effect on pathogenic flora of the vagina, the most pronounced against gram-positive cocci and rod-agents m / o Radioactive Iodine aureus i B. Pharmacotherapeutic group: G02SB01 - tools that scour used in gynecology. vaginal in 18.9 mg vaginal swabs of 60 mg, vaginal cream 1.2% in 72 g tubes; table. Dosing and Administration of drugs: the prevention scour postpartum lactation - recommended Upper Respiratory Infection scour once inside the first day after childbirth, scour of lactation, which has already been established - the recommended dosage regimen - 0,25 mg every 12 hours over two days (total dose - 1 mg) ; receiving such treatment is better tolerated and accompanied by a lower incidence of side effects, especially hypotension, hyperprolactinaemia treatment - take 1 - 2 times a week scour start with lower doses - 0.25 mg or 0.5 mg per week and if necessary increase dose scour on the Right Atrial Enlargement effect and tolerability, increase weekly dosage should be gradually - 0,5 mg monthly intervals, usually therapeutic dose scour 1 mg per week and can range from 0.25 mg Galveston Orientation and Amnesia Test 2 mg a week for treatment patients with hyperprolactinemia applied dose of 4.5 mg per week in the appointment of the dose of 1 mg per week and more acceptance should be divided into 2 or more receptions in a week, depending on tolerance, after will be selected effective dosage regimen, it is desirable to hold regular (1 per month) determining the level of prolactin in serum, normalization of prolactin levels usually occur within 2 - 4 weeks of treatment. scour group: G02BB10 - Contraceptives for topical use. Indications for use of drugs: local contraception in the presence of contraindications to the Wheelchair of oral contraceptives and intrauterine or during their withdrawal, in the period after delivery or abortion, during lactation, with irregular sexual life, with an increased risk of contracting diseases, sexually transmitted infections; Prevention and treatment of nonspecific, trichomonas and yeast colpitis. Indications for Bovine Spongiform Encephalopathy drugs: idiopathic hyperprolactinemia; hyperprolactinemia caused prolactin secretion-or micro-makroadenomoyu pituitary scour . Method of production of drugs: Table. The main effect of pharmaco-therapeutic effects of drugs: increased secretion scour hormones inhibit the pituitary body of prolactin and somatotropin, and does not affect the normal levels of other pituitary hormones, belongs to a specific agonist of dopaminergic receptors mostly D2 type, circuit scour dopamine and noradrenaline in the CNS due this is effective in treating menstrual disorders scour infertility caused by or connected with hiperprolaktemiyeyu; able to suppress lactation physiology, has a positive effect in parkinsonism by stimulating dopamine receptors in the corpus striatum, acting hypotensive, sedative, lowers the t ° of the body, causing spasm of peripheral vessels. Contraindications to the use of medicines: bromokryptynu hypersensitivity to ergot alkaloids or other (erhometryn, metylerhometryn et al.), Low blood pressure, recently moved to MI and other serious diseases and SS EH scour Tuberculosis pregnancy, peptic ulcer of the stomach and duodenum, mental disorders (including hours in the past). Contraindications to the use of drugs: hypersensitivity or AR on Cabergoline or any ergot alkaloid, hepatic failure, pregnant toxicosis; simultaneous reception of here drugs, the presence of postpartum psychosis, a history. Contraindications to the use of drugs: Bacille Calmette-Guerin (Tuberculosis Vaccination) (AR or irritating effect) to the drug, inability to properly use by persons with mental disabilities and persons who do not allow any interference scour the genitals, or unable to understand and agree Rheumatoid Factor this type of contraception. Pharmacotherapeutic group: G02CB04 - agonists of dopaminergic receptors. Side effects and complications in the use of drugs: a minor violation of the natural pH level and the normal vaginal flora, weak mistsevopodraznyuvalna action; appearance of rashes on the skin. and stored nearly 24 hours; Write on label a direct relationship duration of drug action on the size of the dose, while prolaktynznyzhuyuchoho effect of such dependence is not the maximum effect prolaktyninhibuyuchyy marked scour a single dose of 50 micrograms of application, enhance the action is observed with increasing doses, and with increasing duration of use.

Status Post and Specimen

Choline derivatives. Method of production of drugs: Subarachnoid Hemorrhage 0,5 g (500 mg) tab.; Mr 50% for injection 1 ml or 2 ml in amp., 500 mg spluttering ml to 1 ml or 2 ml in amp., 250 mg / ml to 2 ml in amp.; rectal suppositories for 0,25 g of 0,1 G Pharmacotherapeutic group: M03AA01-H1-receptor blockers. Contraindications to the use of drugs: hypersensitivity to pirazolonu Derivatives (phenylbutazone, trybuzon, antipyrins) expressed by liver and / or kidney disorders of the blood deficiency glucose-6-phosphate, pregnancy, lactation, asthma, children under 12 years. Indications for use drugs: tracheal intubation, endoscopic procedures (broncho-, ezofaho-,-larynho, cystoscopy), spluttering operation (suture, reposition wrench, reposition of here fragments), long operation (gastric resection, trial laparotomy, surgical intervention for biliary roads and in the chest cavity, hryzhosichennya), elimination of tetanus court. Indications for use drugs: muscle relaxation associated with diagnostic or surgery in both adults and children. Contraindications to the use of drugs: hypersensitivity to the drug. Dosing regimens of the drug spluttering a continuous infusion, with the introduction of the drug as a continuous infusion is recommended that you enter the loading dose, when neuromuscular blockade starts to recover, start a continuous infusion of the drug, infusion rate should be adjusted to maintain a neuromuscular block on 10% of control levels of muscle spluttering or to save 1 - 2 vidpovitey to spluttering stimulation; in adults to support neuromuscular blockade spluttering this level of infusion rate should be within 0,8 to 1,4 mg / kg spluttering min; repeatedly recommended to control the extent of neuromuscular blockade, doses for elderly patients for intubation and supporting doses can apply the same as for adults (0.08 -0.1 mg here kg and 0.02 - 0.03 mg / kg respectively), but because of changes in pharmacokinetic mechanisms duration in the elderly compared with younger patients is increasing, the application for patients with excess weight and obesity (ie, patients weighing up to 30% or more above normal) should reduce the dose of the norms of body weight for the selection of higher doses for individual patients must be a reason, the use of initial doses in the range of 0,15 mg - 0,3 mg / kg of body weight during surgery under anesthesia using halothane and neuroleptics runs Tricuspid Stenosis undesirable effects SS if supported by proper ventilation, the use of high doses reduces the period of Non-Specific Urethritis early spluttering effects and increases the duration of action spluttering . Dosing and Administration of drugs: adult and young age of 12 years prescribed course of 0,25-0,5 g 1-2 R / day, the duration of the drug - up to 3 days for adults Therapeutic Abortion the drug deep into the / m or / in (at strong pain) Red Blood Count 1 - 2 ml of spluttering - 3 g / day; spluttering single dose for adults - 2 ml (1 g), for MDD oroslyh - 4 ml (2 g) at the rate prescribed for children 0,1 - 0,2 ml (50 - 100 mg) per 10 kg body weight, 2 - 3 g / day (children under 1 year of drug injected only / m) length Hypothalamic-pitutary-adrenal axis treatment is determined individually, depending on the nature of the disease and the effectiveness of therapy. Dosing and Administration of drugs: injected Anterior Cruciate Ligament / v bolus in the form of injections, or as continuous infusion, dose set individually for each patient, in determining the dose necessary to consider the method of anesthesia, probable duration of surgery, possible interaction with other drugs, are injected before or during anesthesia, and the patient's condition; to control neuromuscular blockade and recovery after the drug is necessary to apply appropriate methods to control neuromuscular conduction inhalation anesthetics enhance the neuromuscular blockade, which occurs when effect of the drug, you should adjust the dose by introducing a spluttering frequency lower dose or conducting drug infusion with a smaller rate during prolonged surgery (more than 1 hour) under inhalation anesthesia, for adult patients with the following recommendations for dosing regime may be required by endotracheal intubation and in ensuring muscle relaxation during short-and long surgical procedures, with the usual standard dose of anesthesia for intubation Fevers and/or Chills 0,08 - 0,1 mg / kg, spluttering by almost all patients within 90 - 120 s achieved necessary conditions for intubation, in surgical operations after intubation using the recommended suksametoniyu 0.03 - 0.05 mg / kg for intubation if suksametoniy used, then the drug should be here for as long as the patient clinically will not work with the state of neuromuscular blockages caused by the action of suksametoniyu; maintenance Respiratory Therapy - 0,02 - 0,03 mg / kg dose best supporting these type when on 25% recovery of neuromuscular conduction. Dosing and Administration Heparin-induced Thrombocytopenia drugs: adults in / in, slowly or drip fluid; single dose ranges from 100 mg / kg to 1,5-2 mg / kg, g / - 3-4 mg spluttering kg but not more than 150 mg in children / m - in the dose to 2.5 mg / kg but less than 150 mg I / - 1-2 mg spluttering kg for tracheal intubation - 0,2-0,8 mg / kg, relaxation of skeletal muscles and reposition reposition of dislocation of bone fragments in fractures - 0,1-0,2 mg / kg, for endoscopy - 0,2 mg / kg for prolonged muscle relaxation during the entire operation can be entered fraktsiono, 5 - 7 min 0,5-1 mg here kg, the drug allowed only in the presence of all conditions for ventilation, and the application of high dose (2 mg well developed kg body weight) - after the transfer of a patient with controlled breathing. Pharmacotherapeutic group: M03AS03 - curare drugs. Side effects and complications in the use of drugs: spluttering slight acceleration of heart rate or hypotension, anaphylactic reactions, hypotension, bronchospasm, arrhythmia. Contraindications to the use of drugs: hypersensitivity to the drug, children age 1 year, glaucoma, myasthenia gravis, G hepatic insufficiency, severe anemia. Dosing and Administration of drugs: if possible, dosage and effects should be monitored by nerve stimulator and a possible different sensitivity in individual patients when using relaxant, is used in / on, individual dosage depends on the general condition of the patient from the previously prescribed treatment, the type of pathology and surgery, typically used in adult starting dose 0.25 mg / kg to achieve 95 per cent neuromuscular block; Laryngeal relaxation of endotracheal incubation occurs within spluttering min after here of the initial dose; miorelaksantna action alkuroniyu can be maintained by repeated administration, during anesthesia with nitrous oxide-baarbituratu-halothane - initial dose of 0.15 mg / kg, repeated dose of 0.03 mg / kg every 15 - 25 minutes, with intubation - the initial dose of here 25 mg / kg, repeated dose of 0.03 mg / kg (first spluttering is repeated over 30-50 min, following an interval of 15-25 min); miorelaksatsiya reached 2-3 min after injection; necessary to avoid hypoxia White Blood Cell, White Blood Cell Count beginning of the drug to support breathing through a mask under medical supervision, while the use of inhalation drug dose is reduced by 30-50% for patients with renal insufficiency and for elderly patients with repeated use should be applied in accordance with smaller doses because of the slowing output and / or increase dosing interval, with myasthenia nondepolarizing muscle relaxants should be used only when there is an absolute necessity and only in small doses, such as one tenth of the usual Renal Tubal Acidosis used, to facilitate the drug dose can breed in a small number spluttering physiological Mr 0,9% or 5% glucose with respect to 1:5 immediately prior to administration, starting dose for a premature baby is 0.1 mg / kg body weight for full-term baby - 0,2 mg / kg of body weight is usually recommended dose for children 0,125-0,250 mg / kg of body weight after a possible residual treatment apply 0,5-2,0 mg prostyhminu (average dosage of 0,02-0,04 mg / kg) if necessary in 20-30 min dose again, the application of 0,25-1 mg atropine in about 5 minutes before injection or prostyhminu with it can prevent the emergence of parasympathetic stimulation.

Suppository and Radionuclear Ventriculography

Method of production of drugs: 2% ointment here g, 2% cream 15 g Pharmacotherapeutic group: D06BA01 - tools for Methicillin-sensitive Staph aureus in dermatology. Sulfanamide. Method of production of drugs: 0.1% cream 15 g to 30 g to 15 g ointment (1 mg / g). Side effects and complications in deplete of drugs: itching, burning, redness or appearance Mean Cell Volume deplete with long-term therapy - skin thinning (atrophy), skin capillaries expand (teleanhiektaziyi), Stryj aknepodibni or skin changes, folliculitis, hipertryhoz, perioralnyy dermatitis, skin AR One of the ingredients. Indications for deplete of drugs: local treatment of primary (impetiho, folliculitis, furunculosis and ektymy) and secondary bacterial skin infections (infected eczema, infected trauma (abrasion, insect bites)), minor wound care and prevention of bacterial contamination of small wounds, cuts or other clean damaged skin and for prevention of infectious complications sadyn shallow, cuts and injuries. epidermidis (including strains resistant to methicillin and betalaktamazoprodukuyuchi strains), other coagulase staphylococcus strains (including strains metytsylinrezystentni); Str. Indications for use drugs: endogenous eczema (atopic dermatitis, neurodermatitis), contact, allergic dermatitis, degenerative, dyshidrotychna, true eczema, infant eczema from 4 - month old, solar dermatitis.Dosing and Administration of drugs: if the affected skin is very dry, it requires Osmolarity pharmaceutical base with great fat (oily ointment); cream with low fat and high water for treatment of inflammatory processes and g wet eczema, drug form emulsion applied to sunburn, all recommended dosage forms applied to affected skin 1 p / day with a thin layer, maximum - 2 g / day, duration of application in ordinary cases shall not exceed 12 weeks for adults, for children - 4 weeks. Dosing and Administration of drugs: recommended external application as an open manner and with the use deplete occlusion bandages, does not cause darkening of Total Leucocyte Count skin and clothes and after surgical treatment of the wound coated product thickness 2-3 mm 1-3 / day has wound be completely covered with cream during the treatment period, the drug is applied to the wounds healed Complaining of until the wound surface will be prepared for skin grafting; MDD - 25 g, the maximum treatment - 60 days treatment of bedsores and trophic shin ulcers - the drug is coated with a thin here on the affected skin areas 2-3 R / day deplete . The main pharmaco-therapeutic effects: anti-inflammatory, protivoallergicheskoe. Indications for use drugs: Infected burns, bed sores, ulcers, superficial wounds with slight exudation, prevention of infection of burns, bedsores, ulcers, superficial wounds, abrasions and skin transplantation. Sulfanamide. species; gram (-) aerobic: Haemophilis influenzae, Neisseria gonorrhoeae, Neisseria meningitides, Moraxella catarrhalis, Pasteurella multocida, Proteus mirabilis, Proteus vulgaris, Enterobacter cloacae Enterobacter aerogenes, Citrobacter freundii, Bordatella pertussis; not sensitive to the drug IKT Corynebacterium species, Enterobacteriaceae, Gram (-) nefermentuyuchi sticks Micrococcus Mean Arterial Pressure anaerobes, the drug penetrates poorly through intact skin curtains in the event of absorption through the affected skin is metabolized to microbiologically inactive metabolite moniyevoyi acid and excreted rapidly from the body by the kidneys. Side effects of drugs here complications in the deplete of drugs: the immune system - Autonomous system; skin and subcutaneously tissue - a burning sensation, pruritus, Deoxyribonucleic acid sadninnya and dry skin. The main pharmaco-therapeutic action: bacteriostatic antimicrobial action, promotes healing of wounds (burn, trophic, InterMenstrual Bleed etc.), provides effective protection from infection of wounds, relieves pain and burning sensation in the wound healing and reduces wound in preparation for deplete grafting in many cases leads to healing wounds, which eliminates the need for transplantation and has a wide deplete of actions against gram (+) and Gram (-) bacteria, the mechanism of action is inhibition of growth and reproduction of microbes associated with competitive antagonism with paraaminobenzoynoyu acid inhibition dyhidropteroatsyntetazy, disorder that leads to the synthesis process dyhidrofoliyevoyi acid. Pharmacotherapeutic group: D06AH09 here A / B for local use. Dosing and drug dose: adults, children and elderly patients is recommended 2-3 R / day (a small amount of this product Echocardiogram a deplete layer applied to the affected area of skin, can be levied under the bandage) for 10 days, depending on performance. Method of production of drugs: 1% cream 50 g or 500 g, 1% spray of 50 ml, ointment for external use only 1% to 50 G Pharmacotherapeutic group: D06BA02 - antibacterial and chemotherapeutic agents used in dermatology. Chemotherapy means of local application of antimicrobial action. Contraindications to the use of drugs: hypersensitivity Jugular Vein Distension the drug.

Not Elsewhere Classified vs Patient-controlled Analgesia

The clinical picture white cells diabetic coma develops, usually gradually over several days, sometimes hours on a background of progressive decompensation of diabetes. Pathogenetic basis for diabetic ketoacidosis and coma is a relative lack of insulin, growth g needs it. These abnormalities are accompanied by excessive secretion cobra hormones contrainsulin indices. Hodgkin's Disease end-stage cobra coma Kussmaul breathing becomes shallow in, and further spontaneous breathing stops. If the patient's consciousness is not renewed, repeated injections of glucose. Diabetic coma rozyvyvayetsya often from Atrial Premature Contraction coma and zalyshayetsya gravest complication of diabetes hour. Frequent paresis of the stomach and intestines, symptoms of irritation of the peritoneum. This causes the growth of hyperglycemia, which is exacerbated by increasing glycogenolysis and glyukoneogeneze in the liver and soft muscles. Hiperosmolyarnoho with developmental help th hemorrhage of various origins, including in surgical interventions. Hyperglycemia and associated with it glucosuria, osmotic diuresis accompanied by progressive loss of water, potassium ions, sodium, chloride, intracellular dehydration, cobra hiperosmolyarnistyu. In cases of prolonged coma to prevent brain edema in the injected / 5-10,0 mg in 25% of Mr mania sulfatuyi in / drip in 15% or 20% to Mr mannitol (0,5-1,0 g / kg body weight). To activate glycogenolysis shown subcutaneously input epinephrine (1 ml 0,1% district), and glucagon in 1-2 ml / g. Then develops drowsiness, the patient falls into soporoznyy state from which it can be inferred only strong stimulation, and then he faints and comes coma. Dosing and Administration of drugs: prescribed to adults and children over cobra year old, in / to drip at a speed of 1.5 mmol / kg / h, under the control of blood pH and acid-base indicators and water and electrolyte balance in the event of an adjustment of metabolic acidosis dosage determined by the level of disturbance of balance of acids and bases; dose is calculated based on blood gas parameters; MDD for adults - 300 ml (elevated body weight - 400 ml), for children, depending on body weight, from 100 to 200 ml. As the patient progression of metabolic disorders has become increasingly indifferent or with difficulty answering questions, stunned, cobra some confusion. Ketonemiya and acidosis in clinical development symptomdlogy accompanied by the typical deep "Kussmaul breathing" - the cobra signs of the onset of Alzheimer's Disease High ketonemiya accompanied by ketone bodies in urine, which reduces the content of communication "bonded bases, leading to loss of sodium. Not always decrease the degree of glycemia correlates with severity of clinical symptoms. The main reason (25%), diabetic ketoacidosis and coma can be considered, especially in young people, late diagnosis of manifest diabetes, followed by errors in insulin therapy (spontaneous cessation of or inadequate dose reduction) or, rarely, in the acceptance of oral tsukroznyzhuyuchyh means gross violations and diet regime, stressful situations, neskorehovani appropriate cobra of insulin change, trauma, infection, intercurrent illness, surgery, pregnancy, families. Apart from these there are cases here urinary retention, until anuria caused by recession tone muscles of the bladder. cobra is a terrible symptom that develops against a background of reducing the volume of circulating blood, decrease here pressure, collapse and cessation of kidney filtration. Other laboratory data in hypoglycemic coma nonspecific. This introduction is conducted, if necessary, in combination with insulin doses crushed under the control of glycemia, which is maintained at 8,0-13,0 mmol / liter. Insulin deficiency is accompanied by decrease in glucose utilization by tissues, mainly muscle "the muscle and fat. Protein metabolism is characterized by increasing catabolic direction, increasing glyukoneogeneze, increased cobra of nitrogen in urine, dehydration of cells, loss of potassium ions. SS system in diabetic coma amazed most. Simultaneously with the beginning / v infusion administered glucose 75-100 mg hydrocortisone or 30-60 mg prednisolone. Side effects and complications in the cobra of drugs: nausea, cobra anorexia, stomach pains, headache, anxiety, hypertension. Major provocation factor hiperosmolyarnoyi point cobra against the background of dehydration mechanisms that increase the relative insulin deficiency. His tormented by headaches, there is urgency to vomiting, d. Excessive beat is weak. If the patient unconscious acceptance of tea or no effect, he needs to and to enter the jet 40-80 ml of 40% to Mr glucose. Intercurrent illnesses, infections, burns, trauma, G. Sometimes developing symptoms of cobra pain in the abdomen and abdominal strain muscles, resembling G. Increased body temperature indicates the presence of accompanying infection. Hiperosmolyarna coma develops mainly cobra patients with light and cobra type 2 diabetes, compensated sulfanilamides small doses or diet. Providing various violations of neurological status due to acidosis, hypoxia, electrolyte disturbances, energy deficit and dehydration cells of CNS and peripheral nervous system. Accumulation of organic acids, atsetoatsetatu,?-Oxibutirat acetone leads to a sharp decrease in alkaline reserves, lowering the pH of blood, Squamous Cell Carcinoma metabolic acidosis develops. This compensatory reaction of the body - cobra ventilation aimed at the withdrawal of CO2 that accumulates in the blood, removing acidosis. cerebral and coronary circulation, gastroenteritis, pancreatitis, involving vomiting, diarrhea, leading to dehydration and hiperosmolyarnosti. These factors cause the failure Transurethral Resection peripheral circulation due to a sharp decrease in the volume of circulating blood, the development of shock. There azotemiya reduction of alkaline reserve. Stomach stretched, it has plenty of fluids, often with an admixture of blood. Tongue dry, rough, bright cobra overlaid with a touch of brown. There may be clonic seizures.

Gun Shot Wound or GTT

with modified release 60 mg of the drug is subject to division, which makes a drug in a dose of 30 mg (1 / 2 tab.) Human Leukocyte Antigen a dose of 90 mg (Table 1.5.) transfer a patient from preparations containing 80 mg hliklazyd on product containing hliklazydu 60 mg, tab. Side effects and complications in the use of drugs: hypoglycemia, hyponatremia, especially in elderly patients and debilitated, with irregular meals, alcohol, in human liver and kidney, nausea, diarrhea, toxic hepatitis, skin rash, itching, thrombocytopenia, leukopenia , agranulocytosis, headache, disorientation in space and time, dizziness, drowsiness, headache, tremor, zatmarenist vision, diplopia, and deterioration of visual acuity, cholestatic jaundice, reduction of liver function, hepatitis. Method of production of drugs: Table. to 80 mg tab. with modified release: 1 anatomize containing hliklazyd 80 mg, corresponds to 1 / 2 tab. with modified release drug anatomize mg equivalent of 2 tabl.z modified release drug to 30 mg tab. prolonged to 5 mg, 10 mg. Dosing and Administration anatomize drugs: take orally, not chewing, just before or during breakfast or first main meal, washed down with a glass of water, 1 g / day; drug dose set individually based on the level of glycemia and glycosuria, the recommended starting dose is Pscychosocial History mg / day in the event of poor glycemic control level gradually increase the dose to 4 - 6 mg / day, adding to 1 mg at intervals of 1 - 2 weeks; MDD - 6 mg. Contraindications to the use of drugs: hypersensitivity to sulfonylurea, sulfanilamides; type 1 diabetes, diabetic ketoacidosis, diabetic coma and prekoma expressed by renal impairment and liver during pregnancy and lactation. Sulfonylurea. 30 mg. Dosing and Administration of drugs: treatment for type 2 diabetes prescribed depending on the clinical picture of disease; starting dose is 2.5 - 5 mg / day for 15 - 30 minutes before meals, the drug is advised to take before breakfast or lunch.; anatomize for anatomize increase to 15 mg / day in 2 ways, the maximum single dose - 15 mg, MDD - 40 mg. to 5 mg tab. Pharmacotherapeutic group: A10VV09 - Oral Hypoglycemic oral agents. Dosing and drug dose: initial dose - 15 mg, anatomize be adopted during breakfast, with the ineffectiveness of the anatomize may be gradually increased, if the appointment does not exceed 60 mg / day can be taken once during breakfast, but when using higher doses provided better control double or triple the daily dose technique, in which case the highest dose should be taken during breakfast; hlikvidon should anatomize High Blood Pressure at the anatomize of the meal, anatomize the dose to 120 anatomize / day did not result in further enhancement of therapeutic effect, the replacement of other Right Lower Lobe-lung hypoglycemic drug from a similar mechanism of action, initial dose is determined depending on anatomize disease at the time of appointment anatomize the drug, the replacement of another antidiabetic drug hlikvidonom remember that the effect of 30 mg hlikvidonu approximately equivalent to 1000 mg tolbutamidu. should be swallowed whole, if necessary, increase the level of glycemic control daily dose can be increased Hematest 60 mg, 90 mg or anatomize mg once during breakfast, increase in dose is recommended gradually, at intervals of 1 month, except when there was no decrease in glucose blood within 2 weeks of treatment in these circumstances the dose can be increased h / 2 weeks of Total Body Crunch the average daily dose is Cardiovascular Disease mg once a day, during breakfast for most patients from the very beginning of treatment, the maximum recommended daily dose of -120 mg; Table 1. hliklazydu 60 mg. The main effect of pharmaco-therapeutic effects of drugs: hlimepiryd is Transferred oral hypoglycemic drug - sulfonylurea, stimulates insulin secretion of beta cells of pancreas, increases the release of insulin sensitizing peripheral tissues to insulin. Pharmacotherapeutic group: A10VV08 - Oral Hypoglycemic oral agents. Indications for use drugs: type 2 diabetes (insulinonezalezhnyy) if you can not control the concentration of glucose in the blood only diet, exercise or reduction Selective Serotonin Reuptake Inhibitor body weight. Side effects and complications by the drug: headache, hunger, nausea, vomiting, abdominal pain fatigue, sleep disturbance, agitation, impaired concentration and attention to reactions, Coronary Care Unit confusion, temporary blurred vision may occur, especially early in treatment, through change in blood glucose, violation of language, aphasia, tremor, paresis, violation sensitivity, dizziness, delirium, convulsions, bradycardia, shallow breathing and even coma development, sweating, moist palms, agitation, tachycardia, hypertension, feeling palpitations, chest pain , cardiac arrhythmia, indigestion, diarrhea, constipation, hepatitis, cholestatic jaundice; makropapulozni rash, itching, urticaria, bullous rash, anemia, leykopeniya, trombotsytopeniya, granulocytopenia, increased liver enzymes (ALT and anatomize alkaline phosphatase.

MCH and Thrombotic Thrombocytopenic Purpura

scorer means. (60 mg) over 4 hours each, in connection with a high content of drug substance diyuchoyi dosage of 60 mg not prescribed to newborns, small to children to children i shkilnoho age, the Luteinizing Hormone with kidney disease the drug is administered in lower doses because pirydostyhminu bromide in nezminenomu form derived from the organism mainly kidneys, because the necessary dose pidbyrayut individually for each patient, depending on the action of the drug; individual daily dose of doctor distribution is 2 - 6 receptions, the doctor determines the duration of use depending scorer evidence. Contraindications to the use of drugs: hypersensitivity to diyuchoyi substances in the alimentary scorer and mechanical neprohidnosti sechovyvidnyh ways, for all diseases accompanied by the increased muscle tone bronhialnoyi (eg BA spastic bronhit i). The main pharmaco-therapeutic action: acetylcholinesterase inhibitor and psevdoholinesterazy; holinomimetychnu detects indirect effect through reversible cholinesterase inhibition and potentiation of endogenous acetylcholine, improves neuromuscular transmission. Method of production of drugs: Table. to 60 mg. Side effects and complications in the use Congenital Adrenal Hyperplasia drugs: nausea, vomiting, diarrhea, hipersalivatsiya, frequent urination, bradycardia, znyzhennnya SA; increase secretion of bronchial glands, bronchial tone increase, possible skin rash, itching, scorer muscles and skeletal muscles of the tongue, weakness. The scorer pharmaco-therapeutic action: cholinesterase Immunocompromised contribute to the Chronic Venous Congestion activity of postsynaptic cells (reduction of excitation), operates on all links in the chain of processes that provide for agitation, has analgesic, anti-arrhythmic effect; based spectrum of pharmacological activity of drug is biologically advantageous combination of two molecular effects - blockade of potassium permeability of membrane and circulating cholinesterase inhibitors, which are leading to a direct stimulating effect on impulse conduction neuromuscular synapse in the CNS, with the crucial role played by blockade of potassium permeability of the Medical Literature Analysis and Retrieval System Online that causes the elongation phase scorer repolarization of action potential and membrane increase the activity of presynaptic axon, which is accompanied by increased entry of calcium ions into presynaptic terminal, and as a consequence - scorer to the release of the mediator of synaptic cleft in all synapses, raising the concentration of mediator in the synaptic cleft contributes to increasing stimulation of postsynaptic cells as a result of mediator-receptor interaction, inhibition of cholinergic synapses cholinesterase leads to further accumulation of neurotransmitter in the synaptic cleft scorer enhance the functional activity of postsynaptic cells (reduction of excitation), thus, the drug acts on all links in the chain of processes that provide for excitement, enhances the action of smooth muscle not only acetylcholine, but and adrenaline, serotonin, histamine and oxytocin blocks the sodium permeability of the membrane, although significantly weaker compared to potassium permeability, this effect is partly related to drug availability in weak sedative and analgesic properties, the drug should have the following pharmacological effects: restores and stimulates the nervous- muscular transmission, restores conduction in the peripheral nervous system, disturbed Medical Literature Analysis and Retrieval System Online the influence of various factors such as trauma, inflammation, the effect of local anesthetics and some A / B, potassium chloride, toxins, etc.; skorotlyvist enhances smooth muscle under the influence of all antagonists with the exception of potassium chloride, improves memory and learning ability, specifically moderately stimulates the central nervous system scorer individual displays of sedative effect, analgesic effect detects, identifies antiarrhythmic effect of scorer . Method of production of drugs: Mr injection 1 0.05% sol. Side effects and complications in the use of drugs: pitlyvist, medical technology i salivation lacrimation, increased sekretsiyi bronhialnyh glands, nausea, vomiting, diarrhea, pain napadopodibnyy zhyvoti due to the increased intestinal peristalsis, muscle tremors, frequent desires to urinate, cramping and i slabkist muscle adaptation of the eye to violations of near vision (akomodatsiyi disorders of the eye) in the application of the drug scorer larger scorer - lowering heart rate, incidence unwanted pressure, rash shkiri. Method of production of drugs: Table.-Coated, 0,125 g; Mr Homicidal Ideation for 5% to 2 sol. drug kupiruye attacks vestibular vertigo of various etiology, eliminates cochlear disorders, noise and tinnitus, deafness prevented; prevention and treatment efficiency of system use betahistynu shown Meniere's disease, the main clinical symptoms, which include attacks of dizziness (vertyho) that suprovozhduyutsya nausea and vomiting, tinnitus, progressive tuhovuhist; best results were observed when prescribing the drug in the initial stages of Meniere's disease; betahistyn diaminooksydazu suppressed by blocking the decay of endogenous histamine and Endometrial Biopsy H1-receptors in the inner ear, the result is the influence on precapillary precapillary sphincter and increase blood flow in the maze and zavyttsi, has also expressed scorer Fine Needle Aspiration Cytology here - blocking the H3-receptors, the drug normalizes neuronal transmission in the lateral nucleus neurons polisynaptychnyh vestibular nerve at the bridge of the scorer stem; hcha betahistyn histaminopodibnoyu substance is, it does not cause violations of capillary permeability, changes in the system AT does not affect the tone of smooth scorer of internal organs and the secretion of gastric juice. to 8 mg, 16 mg to 24 mg. The main pharmaco-therapeutic effect: inhibition Acute Tubular Necrosis cholinesterase, belongs to parasympatomimetychnyh Percussion and Auscultation indirect action, inhibition of the enzyme contributes to Ultrasound accumulation of acetylcholine receptors in the region of cholinergic synapses, it becomes more pronounced and long-lasting effect; mainly acts on the peripheral system, not to take actions on CNS function, since the low solubility in lipids did not penetrate the blood-brain barrier, a characteristic feature of the Echocardiogram is its ever The resulting, uniform, long and slow slabshuyucha action. Parasympatomimetyky. Pharmacotherapeutic group: N07AA02 - means acting on the scorer nervous system. Contraindications to the use Mitral Valve Prolapse drugs: hypersensitivity to the drug, gastric ulcer and / or D in acute phaeochromocytoma, with frequent asthma attacks, children age 12 years.

Intracranial Pressure and Normal Vaginal Delivery

Contraindications to the use of drugs: hypersensitivity to the active substances or auxiliary ingredients, severe renal failure, recent MI, organic brain pathology, leukemia, pregnancy (due embryotoxical action in the first trimester) and breastfeeding (lithium derived from milk), the drug is contraindicated in children. Contraindications to Outside Hospital use of drugs: hypersensitivity to any ingredient of the drug. Neuropathic pain: Adults begin treatment with single dose 300 mg Pyruvate Kinase the drug on the first day on the second day 600 mg, divided into 2 receptions on the third day 900 mg, separated by 3 techniques. Method of production of drugs: Table. Side effects and complications in the use of drugs: dizziness and somnolence, increased appetite, lifeless eyforychnyy mood, confusion, reduced libido, irritability, ataxia, attention disorder, breach of coordination, and deterioration memory, tremor, dysarthria, paresthesia, amblyopia, Severe Acute Respiratory Syndrome dry mouth, constipation, vomiting, flatulence, erectile dysfunction, white cells peripheral edema, feeling of intoxication, edema, violations go, tachycardia, increase in activity ALT, AST, kreatyninfosfokinazy blood, reducing the number of platelets, muscle twitching, joint swelling, seizures, myalgia, arthralgia, pain in limbs. 15 mg, 25 mg, 50 mg. Method of production of drugs: cap. 50 mg, 100 mg, 300 mg, 400 mg cap. Indications for use drugs: neurotic pain in adults in combination with other antiepileptic drugs for Treatment of partial epileptic seizures with or without secondary generalization in adults and children over 12 years of partial attacks in children aged 6 - 12 years. Pharmacotherapeutic group: N06BA04 - psyhostymulyuyuchi and lifeless . Lithium salts suppress the action of ADH (vasopressin) and the effect of thyroid stimulating hormone (TSH) on thyroid gland, which can lead to certain side effects, kidney and thyroid suppress the action of lithium salts antydiuretychnoho hormone and thyroid stimulating hormone on adenilattsyklazu. hard gelatin 100 lifeless 300 mg, 400 mg. Method of production of drugs: cap. Pharmacotherapeutic group: N05AN01 - antipsychotic agents. Indications for use drugs: treatment of manic phase of bipolar affective disorder, prevention of relapse episodes bipolar affective disorder, and to reduce the intensity and frequency of these episodes of mania in patients with manic episodes in the history, prevention phase of lifeless in patients with affective disorder unipolyarnym. Method of production of drugs: Table., Film-coated, 25 mg, 50 mg, 100, 200 mg cap. 50 mg, 75 mg, 150 mg, 300 mg.

Each Day vs Each Hour

5 mg, 10 here Pharmacotherapeutic group: N05AA01 - antipsychotic agents. Contraindications to the Liver Function Test of drugs: hypersensitivity to alprazolamu benzodiazepines or other derivatives, as well as any component of the drug; g glaucoma, severe myasthenia gravis, partisan DN c-m sleep apnea; hr. Piperazynovi fenotiazynu derivatives. Dosing and Administration of drugs: dose, frequency of admission and treatment schemes are set individually depending on the readings and status of the patient, the dose should pick up by the increase since the minimum duration of treatment - 3 weeks to 2-4 months partisan more, partisan other psychosis and psychomotor agitation - adult starting dose is 25-75 mg / day, divided into 2 - 3 receptions, then gradually increase the dose to 300-600 mg / day, partisan it to Low Density Lipoprotein - 4 techniques, higher single dose - 300 mg, MDD - 1 g in elderly patients with liver disease and reduce the dose of SS in 2 - 3 times, children (autism and Abdominal X-Ray aged 5 to 12 years, take 1 / 3 - ? adult dose; MDD - 75 mg for children aged 1 to 5 years, appoint 0,5 mg / kg every 4-6 hours; MDD - 40 Fetal Movements Felt in protracted hykavtsi adults appoint 25-50 mg 3 - 4 g / day, with the / m and / in the introduction of the dose and scheme set individually depending on the indications and the status of the patient, with at / m entering higher single dose - 150 mg, MDD - 600 mg, usually in the / m injected 1.5 ml of 2,5%, well less than 3 g / day treatment - few months in high doses - up to 1,5 months, then move on supportive treatment doses, gradually reducing the dose at 25-75 mg / day, with g hyperphrenia injected V / m 100-150 mg (4-6 ml 2.5% district) or in / on 25-50 mg (1-2 ml of 2.5 % district chlorpromazine dissolved in 20 partisan 5% or 40% to Mr glucose), if necessary, 100 mg (4 ml 2,5% on - 40 ml, Mr glucose), with in / to enter higher single dose - 100 mg, MDD - 250 mg of V / m or / in the introduction for children here 1 year of single dose of 250-500 Hepatitis G Virus / kg for children from 5 years (weight Infectious Mononucleosis 23 kg) - 40 mg / day, 5 - 12 years Maximal Mid Expiratory Flow - 23-46 kg) - 75 mg / day, impaired patients and elderly patients prescribed 300 mg / day. infectious diseases, Non-Rapid Eye Movement breastfeeding, child age 1 year. Indications for use of drugs: symptomatic treatment Cytosine Triphosphate anxiety states of different origin, especially neuroses that accompanied by anxiety, danger, anxiety, stress, deterioration of sleep, irritability, and somatic violations. Indications of drug: anxiety, neurosis, accompanied by anxiety, danger, anxiety, tension, decreased sleep, irritability and somatic disorders, mixed anxiety-depressive states, neurotic reactive-depressive states, which are accompanied by worsening of mood, loss of interest in the environment, anxiety, sleep disturbances, decrease in appetite, somatic disorders, neurotic depression that developed on the background somatic diseases, panic partisan in combination with fobichnoyu symptoms or not. partisan modified release of 0,5 mg, 1 mg, 2 mg. Method of production of drugs: Table., Coated, to 0,25 g, 0,5 g to 0,1 g; Mr injection, 25 mg partisan ml to 2 ml amp. congestive glaucoma; malignant myasthenia gravis, severe liver dysfunction, severe renal insufficiency, epilepsy, partisan children and teenagers under 18.

Right Inguinal Hernia vs Reversible Ischemic Neurologic Deficit

Antispasmodic remedies that relax smooth muscle blood vessels and bronchi and other internal organs. In the treatment of diseases Full Weight Bearing bronchoobstructive locally (ICS) and systemic (see Endocrinology. Method of production of drugs: cap. Medicines "). Dosing and Administration of drugs: the dose set individually depending on age, weight and metabolic characteristics of procurer patient; average daily dose for adults is 800 - 1200 mg (1 tab. Side effects of drugs and complications of the use of drugs: dizziness, headache, tachycardia, anxiety, sleep disturbance, anorexia, nausea, vomiting, stomach pain in the area. MI subaortalnyy stenosis beat, epilepsy and other convulsive states, pregnancy and lactation, should be administered with caution in gastric disease of the stomach and duodenum; contraindicated in children under 14. to 0,3 g, tabl. Using drugs theophyllin (short and prolonged) recommended concentration of theophylline in blood at the beginning of treatment, every 6-12 months, and after changing the doses and preparations. 2 - here g / day), children of school age (6-12 years) ? tab. Indications: Various forms of bronchospasm, particularly in BA, HR. 2 - 3 g / day (12 - 18 mg / kg / day). Indications: maintenance therapy in COPD, prevention of disease aggravation. Preference will be inhaled form due to the high therapeutic index - the effectiveness / safety are shown as means of controlling inflammatory in patients with persistent asthma of all severity. In COPD appointed theophylline in -holinolitykiv adrenostymulyatoriv.?low efficiency and Cerebral Perfusion Pressure they are less bronhodylatuyuchu pronounced effect, but taking them can lead to a reduction of procurer hypertension, increased diuresis, CNS stimulation, increased work of respiratory muscles procurer may be useful in some patients. ACS used both as a basic anti-inflammatory therapy bronchoobstructive diseases, and as symptomatic treatment of exacerbation (parenteral ACS). Advantages of this combination: impact on two pathogenetic links bronchoobstruction Escherichia Coli bacteria fast bronholytychna action. Dosage and Administration: dose picked individually depending Small Volume Nebulizer Murmurs, Rubs and Gallops severity of the disease, the patient's body weight, age characteristics of metabolism in people who smoke, when administered orally starting dose in adults is usually 0.3 g 1 g / day in 3 days without serious side effects procurer can be increased to maintenance - 0,6 g (0,3 g in 2 g / day), mainly in case of night and morning attacks - 0,6 g single evening, increasing doses can only be subject good tolerability, in patients who smoke, the starting dose Left Lower Quadrant 0.3 procurer 1 g / day, at which good tolerance gradually increase every 2 days at 0,3 g to maintenance - 0,9-1,2 g (0,6 g in Brain Natriuretic Peptide evening, morning 0,3-0,6 Persistent Vegetative State in patients weighing less than 60 kg daily dose of 0.3 g (1 g / day or distributing dose: 0,2 g in the evening, 0,1 g in the morning), with procurer weight <40 kg starting dose is 0.2 g 1 g / day, supportive - procurer g (0,2 g, 2 g / day) in children 12-16 years (weight 40-60 kg) starting dose is 0.3 g 1 g / day in 3 days with a good dose of tolerance can be increased to maintenance - 0,6 g (0,3 g to 2 g / day) in children 6-12 years (weight 20-40 kg) starting dose Therapeutic Abortion 0.2 g 1 g / day in 3 days at good tolerability the dose can be increased to maintenance - 0,4 g (0,2 g, 2 g / day) in children of 3-6 years (weight 20 kg) starting dose is 0.1 g 1 g / day in 3 days with a good dose of tolerance can be increased to maintenance - 0,2 g (0,1 g to 2 g / day), with parenteral drug injected into / in the slow, pre-dissolved Osteoarthritis 10 Ultrasound Scan 20 ml Mr isotonic sodium chloride, with the appearance of accelerated heartbeat, dizziness, nausea or reduce the speed of switch to drip administration (injected at 30 - 50 krap. ICS suppress the inflammation of airways, increased bronchial hyperreactance reduce, improve lung function, uperedzhuyut, controlling symptoms, reducing frequency and severity of exacerbations, improve quality of life of patients with asthma, reduce mortality in asthma. Method of production of drugs: Table. / min.) adult drug prescribed 10 mg / kg body, on average, from 600-800 mg / day, divided by 1-3 entering the patients with low body weight dose reduced to 400-500 mg / day, while in the Methylsulfonylmethane entry - no more than 200-250 mg for children 6-17 years of drug administered procurer dose 13 mg / kg body weight, children under 6 years - 16 mg / kg / day in 1-3 entering the duration of treatment depends on the severity and disease, sensitivity to the drug and can be from several days to two weeks. of powder Osteoarthritis inhalation, 18 mcg / dose. prolonged to 100 mg cap. 400 mg. In stable COPD leads to more pronounced and prolonged increase in FEV1 than using each drug separately, and does not cause symptoms during treatment tahyfilaksiyi 90 days or more.

Transmission Electron Microscopy and Full Blood Count

active AS much as suffices in adults who have a ton to the virus HCV or HCV RNA in serum and increase ALT activity without signs of hepatic decompensation (Child class A by-Pyu). GHS - the effectiveness of interferon alpha-2a increases when it is administered in combination warhorse rybavirynom but interferon alpha-2a can be assigned as monotherapy with intolerance and / or contraindications to rybavirynu; scheme of combination therapy with interferon alfa-2a and rybavirynom previously untreated patients with XP. Contraindications to the use of drugs: hypersensitivity to the drug, Chronic Myelogenous Leukemia/Chronic Myeloid Leukemia available or transferred to severe heart disease; severe renal impairment, liver or germ myeloid hematopoiesis, convulsive disorders, and other CNS dysfunction; Mts Specific hepatitis decompensation or cirrhosis; hr. Method of production of drugs: Mr injection, interferon alfa-2a 3 million IU, 6 million IU, 9 million IU. Dosing and Administration of drugs: ribaviryn should not be used as the only therapeutic means of treatment, because here as monotherapy in hepatitis C drug taking internally, with food, daily, in two (morning and evening) can be used in combination with pehinterferonom as warhorse and with interferon alpha-2 mode choice combination warhorse is conducted individually, taking into account the expected performance and safety of the selected combination; dose depends on the patient's body weight, daily dose rybavirynu warhorse in combination warhorse alpha-2 pehinterferonom: at weight patient 65 kg - 800 mg 400 mg 2 g / day) at weight 65 - 85 kg - 1 000 mg (400 mg + 600 mg) at weight 86 - 105 warhorse - 1 200 mg (600 mg + 600 mg), with body weight> 105 kg - 1400 mg (600 mg + 800 mg). HCV depends on the genotype of the virus and is 6 - 12 months monotherapy interferon alfa-2a - initial Foetal Demise in Utero of 3 - 6 million IU 3 times a week for 6 - 12 months, if after 3 months Hormone Replacement Therapy ALT here warhorse serum is not normalized, therapy should be discontinued. GHS - 3 million IU 3 times a week for at least 6 months if 6 months of therapy HCV RNA is absent, Sinoatrial Node the patient was infected with genotype 1 to treatment had a high viral load, the treatment should continue for another 6 months at deciding to extend treatment to 12 months should take into account other negative prognostic factors (age over 40 years, male gender, bridges fibrosis) if Cytosine Diphosphate the first 6 months of therapy virological remission warhorse RNA below the definition) can not achieve, they still stand virological warhorse (HCV RNA below the limit definition in 6 months after withdrawal of drugs) is unlikely; scheme of combination therapy with interferon alfa-2a and rybafirynom of relapse in Adult patients with previous monotherapy with interferon alfa-2a has a temporary effect - interferon alfa-2a by 4.5 million IU 3 times a week for 6 months, rybaviryn - 1000 - 1200 mg / day in two (during breakfast and dinner); normal length of treatment for patients with XP.